Early Signs of Ovarian Cancer, and How to Help Reduce Your Risk
You can’t screen for it, and signs and symptoms are often subtle
Category: Oncology
‘Tumor Boards’ Bring Many Experts to One Patient
Physicians meet in “tumor boards” to craft a plan for complex cases.
Meet Your Cancer Care Team
From oncologists to financial navigators, you have a group of experts ready to support you.
The Ras Tracker
For more than 20 years, Sharon Campbell, PhD, has been studying Ras, a protein implicated in 30 percent of all cancers. Now she’s on the hunt for alternative ways to shut the protein down.
UNC Lineberger researchers develop new approach to identify “driver...
Eight breast cancer genes identified using new approach
Improved ultrasound imaging provides alternate way to visualize tumors
The new technique, developed by UNC researchers, would be cheaper and could allow doctors to visualize tumors without the use of radiation.
Promising new therapy in a smaller package
A new microbeam emitter developed at the University of North Carolina at Chapel Hill by a team led by UNC Lineberger member Otto Zhou has the potential to bring a promising new form of radiation therapy into clinical use.
From hospice volunteer to cancer doctor
Five questions for Ronald Chen, a James Woods Young Faculty Award recipient dedicated to bettering treatment for cancer patients.
UNC Lineberger discovery goes from the lab to the patient with FDA ...
New test uses PAM50 breast cancer gene signature discovered by UNC’s Perou
Abiraterone acetate delays quality of life decline in men with meta...
Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.
The value of randomized clinical trials in radiation oncology clini...
Are there enough clinical trials data to guide every radiation oncology decision in a cancer patient's care? Not necessarily, according to a UNC School of Medicine study.
Novel monoclonal antibody inhibits tumor growth in breast cancer an...
The antibody, created at the University of North Carolina, is the first therapeutic discovered that targets a protein known as SFRP2.